Manufacturer record
Biocore Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Biocore Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between December 2023 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BL25-049A, Levosalbutamol, Ambroxol Hydrochloride, Guaiphenesin & Menthol Syrup (exp Apr 2027). DTL, Chennai-06 (state lab) found it not of standard quality: Content - Levosalbutamol in Levosalbutamol Sulphate and Ambroxol Hydrochloride. Listed in the August 2026 alert.
Records by type
5 records linked to Biocore Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levosalbutamol, Ambroxol Hydrochloride, Guaiphenesin & Menthol Syrup | Batch BL25-049AMfg May 2025 · Exp Apr 2027 | Content - Levosalbutamol in Levosalbutamol Sulphate and Ambroxol HydrochlorideOther | DTL, Chennai-06State lab | Aug 2026 |
| Dextromethorphan Hbr, Chlorpheniramine Maleate & Phenylephrine HCl Syrup | Batch BL25-380AMfg Nov 2025 · Exp Oct 2027 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Phenylephrine HydrochlorideAssay | RDTL, ChandigarhCDSCO lab | Feb 2026 |
| Levosalbutamol, Ambroxol Hydrochloride & guaiphenesin Oral Drops | Batch BL24-249Mfg Nov 2024 · Exp Oct 2026 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Rabeprazole sodium (GR) and domperidone (PR) Capsules | Batch BC24-144Mfg Mar 2025 · Exp Feb 2027 | The contents of Rabeprazole Sodium found to be 16.36mg/cap (81.8%) against the label claim of 20 mg/cap in the above referred sample.Labelling | State Drugs Laboratory, PunjabState lab | Aug 2025 |
| Telmisartan Tablets IP 40 mg (Telmibeck-40 Tablets) | Batch BT23-297Mfg Jul 2023 · Exp Jun 2025 | Dissolution of TelmisartanDissolution | RDTL ChandigarhCDSCO lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.